Evidence map›Paper›PMID 41425713›Full record

ReviewOncology research2025

Mast Cells in the Solid Tumor Microenvironment: Multiple Roles and Targeted Therapeutic Potential.

Chenglu Lu, Huiting Zhang, Ujjal K Bhawal, Lei Wang, Jingwu Li, Pangzhou Chen, Lewei Zhu

Abstract readReview
In one paragraph

Review in Oncology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chenglu LuDepartment of Pathology, Hebei Key Laboratory of Molecular Oncology, The Cancer Institute, Tangshan People's Hospital, Tangshan, 063001, China.
Huiting ZhangDepartment of Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Ujjal K BhawalCenter for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha Medical College and Hospitals, Saveetha University, Chennai, 600077, India.
Lei WangDepartment of Pathology, Hebei Key Laboratory of Molecular Oncology, The Cancer Institute, Tangshan People's Hospital, Tangshan, 063001, China.
Jingwu LiDepartment of Pathology, Hebei Key Laboratory of Molecular Oncology, The Cancer Institute, Tangshan People's Hospital, Tangshan, 063001, China.
Pangzhou ChenDepartment of Breast Surgery, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, 528000, China.
Lewei ZhuThe First People's Hospital of Foshan (The Affiliated Foshan Hospital of Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Foshan, 528000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment (TME) is a complex network composed of non-tumor cells, extracellular matrix, blood vessels, and various molecular signals that surround and profoundly influence tumor progression. As one of the key immune effector cells within the TME, mast cells (MCs) exhibit functional complexity, and their specific roles remain widely debated. Depending on the cancer type, spatial distribution, and interactions with other TME components, MCs can demonstrate dual regulatory capabilities-either promoting or inhibiting tumor growth. This characteristic has made them an important focus in current tumor immunology research. This review aims to systematically review the current understanding of MCs in the TME, with emphasis on their characteristics and functional differences across various tumor types, pathological status, and species. In recent years, advances in the understanding of MC markers, activation mechanisms, and biological functions have made targeting specific MC subsets an emerging therapeutic strategy. By comprehensively examining the origin, activation mechanisms, cellular interactions, and therapeutic regulation of MCs, this review provides new perspectives and a basis for future directions in tumor research and treatment.

Indexed as

Mast CellsNeoplasmsTumor MicroenvironmentAnimalsHumansMolecular Targeted Therapycell communicationimmunomodulatorymast cellmast cell activationtargeted therapyTumor microenvironment

Identifiers

PMID41425713
PMCPMC12712666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.